Hair supplementation is a growing business. Nutrafol, the fastest rising nutraceutical supplement for healthy hair growth for men and women, has closed its series A financing round with Unilever Ventures acting as lead investor after an initial introduction from investment platform CircleUp.

Frustrated by poor results and undesirable side effects from a leading pharmaceutical drug, Nutrafol’s co-founders challenged the science behind conventional hair loss solutions. In 2015 they teamed up with world-renowned hair loss experts in the field of dermatology and integrative healthcare to develop a nutraceutical hair growth supplement composed of clinically-tested ingredients. With continued investment in research and clinical studies, Nutrafol is poised to take the lead in the fragmented multibillion dollar global hair loss industry.
 
“Up until now, physicians have had very few, if any, healthy options to offer patients concerned with poor hair health,” says Nutrafol’s president Roland Peralta. “Our researchers created an award-winning solution that fills the void by providing the medical community a healthy and effective option, without side effects, for their patients in the treatment of poor hair health.”
 
“Hair loss is a global issue affecting millions of men and women every day. The founding team at Nutrafol, a nutraceutical supplement, has done a phenomenal job disrupting the status quo of the hair loss industry by shifting the paradigm in how western medicine talks about hair loss,” says Stephen Willson, Investment Director, Unilever Ventures. “Consumers are demanding natural solutions that work- the high trajectory growth of the brand is indicative that Nutrafol is on the frontier of that.”
 
For more on ingestible beauty, check out the latest edition of Happi.